IL17A and gastric cancer: There is no significant difference in IL-17 levels between gastric cancer patients and healthy individuals. Early gastric cancer patients exhibit significantly higher average IL-17 levels, while late-stage gastric cancer patients have IL-17 concentrations comparable to those observed in healthy individuals.